ArticleTherapeutic advances in medical oncology2020

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202).

Xiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.